These results show that RanBP9 is required for cofilin-actin pathology and the hallmark accumulation of Aβ, and thus its reduction facilitates a decrease in the neurotoxicity associated with AD (Woo et al., 2015). The gene discussed is CFL1; the disease is Alzheimer disease.